REMS most commonly stands for two things depending on the context. In sleep science, REM stands for Rapid Eye Movement, a distinct stage of sleep characterized by quick, darting eye movements beneath closed eyelids. In pharmaceutical safety, REMS stands for Risk Evaluation and Mitigation Strategies, a drug safety program required by the FDA for certain high-risk medications. Both meanings come up frequently in health contexts, so here’s what each one involves and why it matters.
REM Sleep: Rapid Eye Movement
REM sleep is one of the major stages your brain cycles through each night. It gets its name from the rapid, irregular eye movements that occur during this phase, which researchers first observed in the 1950s. But the eye movements are just one piece of a much more active picture. During REM sleep, your brain’s electrical activity closely resembles wakefulness, with fast, low-amplitude brainwaves that look almost identical to what you’d see on a brain scan of someone who is alert and awake. This is why some scientists call it “paradoxical sleep”: your brain is highly active, but your body is essentially paralyzed.
That paralysis is deliberate. Your brain releases two chemical signals, GABA and glycine, onto the motor neurons that control your skeletal muscles. Both are required to keep you still. This temporary shutdown prevents you from physically acting out your dreams, which tend to be longer, more vivid, and more emotionally charged during REM than in other sleep stages. Your heart rate and breathing also become irregular during this phase, and your body loses some of its ability to regulate temperature.
How Much REM Sleep You Get
A typical night of sleep contains several REM periods that grow longer as the night goes on. Your first REM episode usually lasts just a few minutes. By the final sleep cycle before waking, a single REM period can stretch to about 30 minutes. Most adults spend just over 20% of their total sleep in REM. That percentage dips slightly with age, dropping to around 17% by age 80.
Why REM Sleep Matters
REM sleep plays a central role in how your brain processes emotions and locks in memories. Emotional experiences from the day are consolidated during REM, meaning they get integrated into your existing memory networks so they can inform future decisions and behavior. This processing appears to be closely tied to dreaming. The same brain structures involved in emotion and reward are also the ones most active during dreams, suggesting that dreaming may be part of how your brain sorts through emotionally significant experiences. Researchers have found that the consolidation advantage for emotional memories over neutral ones is strongest during REM sleep specifically.
When REM Sleep Goes Wrong
In REM sleep behavior disorder, the normal muscle paralysis fails. Instead of lying still during dreams, people kick, punch, flail their arms, shout, or even jump out of bed. They’re physically acting out their dreams, often vivid ones involving being chased or defending themselves. The underlying cause is a breakdown in the nerve pathways that normally suppress muscle movement during REM.
This condition is more common in people over 50 and is a known risk factor for neurodegenerative conditions like Parkinson’s disease and Lewy body dementia. Certain medications, particularly some antidepressants, can also trigger it. Other risk factors include pesticide exposure, smoking, and previous head injury.
FDA REMS: Risk Evaluation and Mitigation Strategies
In a completely different context, REMS refers to a drug safety program that the U.S. Food and Drug Administration can require for medications with serious safety concerns. The goal is straightforward: make sure a drug’s benefits outweigh its risks by building specific safeguards into how the drug is prescribed, dispensed, or monitored. As of May 2025, there were 77 active REMS programs in the United States, and 71 of those included the most restrictive type of requirements.
What a REMS Program Includes
REMS programs vary in complexity depending on the risk involved. At the simplest level, a program might require the manufacturer to distribute a medication guide, a patient-friendly handout explaining the drug’s risks and how to use it safely. A step up from that is a communication plan, where the manufacturer must reach out directly to prescribers, pharmacists, and nurses with information about a specific danger and how to minimize it.
The most restrictive REMS programs include what the FDA calls “elements to assure safe use.” These can impose significant requirements on everyone in the chain:
- Prescriber certification: Doctors may need specialized training or certification before they can write a prescription for the drug.
- Pharmacy certification: Pharmacies that dispense the medication may need to complete training and implement specific procedures.
- Restricted settings: Some drugs can only be given in hospitals or certified healthcare facilities.
- Lab testing: A prescription may only be filled if accompanied by specific test results proving it’s safe to proceed.
- Patient monitoring: Patients may need to undergo regular check-ins during or after treatment.
- Patient registries: Some programs require every patient taking the drug to be enrolled in a tracking registry.
What This Looks Like in Practice
One example involves an injectable antipsychotic used to treat schizophrenia. The medication carries a risk of a rare reaction called post-injection delirium sedation syndrome, where patients can become extremely drowsy, confused, or even lose consciousness within three hours of receiving the injection. The risk is small, occurring in less than 1% of injections, but serious enough that the REMS program requires every injection to be given in a certified healthcare facility where the patient can be observed for at least three hours afterward. The drug simply cannot be administered anywhere else.
If you’re prescribed a medication that has a REMS program, the practical impact depends on the program’s requirements. You might just receive an extra informational handout from your pharmacist. Or you might need to sign an enrollment form, get regular blood tests, or visit a specific clinic for treatment. Your prescriber or pharmacist will walk you through whatever applies.